Suppr超能文献

豚鼠细胞色素P450 CYP2B亚家族通过代谢中间体复合物形成的组织特异性表达、诱导和抑制。

Tissue-specific expression, induction, and inhibition through metabolic intermediate-complex formation of guinea pig cytochrome P450 belonging to the CYP2B subfamily.

作者信息

Yamada H, Kaneko H, Takeuchi K, Oguri K, Yoshimura H

机构信息

Faculty of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan.

出版信息

Arch Biochem Biophys. 1992 Dec;299(2):248-54. doi: 10.1016/0003-9861(92)90271-w.

Abstract

The tissue-specific expression and induction of P450GP-1, a constitutive form of cytochrome P450 of the guinea pig classified into the CYP2B subfamily, were studied. Prior to these studies, a P450 form (P450GP-1 PB) was purified from phenobarbital-treated guinea pigs and the properties were compared with those of the P450GP-1. This form was judged to be the same as P450GP-1 existing in untreated animals by comparisons of their N-terminal amino acid sequences, peptide maps, and affinities toward anti-P450GP-1 antibody. Immunostaining of P450GP-1 revealed that the lung and small intestine as well as the liver of untreated guinea pigs contain P450GP-1, while none or only small amounts of this P450 form were observed in the kidney, heart, spleen, urinary bladder, and testis. The amount of liver P450GP-1 protein expressed in untreated guinea pigs was estimated to be 19.4% of the total cytochrome P450 and this form was increased 1.7-fold by phenobarbital treatment. Similarly, intestinal P450GP-1 was increased by phenobarbital treatment. However, lung P450GP-1 was not increased by the treatment. It was also observed that the liver P450GP-1 is induced with SKF-525A to the same extent as with phenobarbital. On the other hand, dexamethsone, p,p'-dichlorodiphenyltrichloroethane, and isosafrole showed no or only a weak ability to increase the liver P450GP-1 content. The drug-metabolizing activities in the liver microsomes of SKF-525A-pretreated guinea pigs were lower than those in phenobarbital-treated animals, although the P450GP-1 protein was induced equally by these treatments. The low activities of SKF-525A-treated animals in the drug metabolisms were attributed to the formation of the metabolic-intermediate complex between P450GP-1 and SKF-525A metabolite. These results permitted us to conclude that the tissue specificity in the expression of guinea pig P450 belonging to the CYP2B subfamily and the inducibility with chemicals are similar to those of rat CYP2B1, although the constitutive expression of guinea pig liver P450GP-1 is much higher than that of CYP2B1.

摘要

对豚鼠细胞色素P450的一种组成型形式P450GP - 1(分类为CYP2B亚家族)的组织特异性表达和诱导情况进行了研究。在这些研究之前,从苯巴比妥处理的豚鼠中纯化出一种P450形式(P450GP - 1 PB),并将其性质与P450GP - 1的性质进行了比较。通过比较它们的N端氨基酸序列、肽图以及对抗P450GP - 1抗体的亲和力,判断这种形式与未处理动物中存在的P450GP - 1相同。P450GP - 1的免疫染色显示,未处理豚鼠的肺、小肠以及肝脏中含有P450GP - 1,而在肾脏、心脏、脾脏、膀胱和睾丸中未观察到或仅观察到少量这种P450形式。未处理豚鼠肝脏中表达的P450GP - 1蛋白量估计占细胞色素P450总量的19.4%,这种形式在苯巴比妥处理后增加了1.7倍。同样,苯巴比妥处理使小肠中的P450GP - 1增加。然而,肺中的P450GP - 1未因该处理而增加。还观察到,SKF - 525A诱导肝脏P450GP - 1的程度与苯巴比妥相同。另一方面,地塞米松、对,对'-二氯二苯三氯乙烷和异黄樟素对增加肝脏P450GP - 1含量无作用或作用较弱。尽管这些处理对P450GP - 1蛋白的诱导程度相同,但SKF - 525A预处理的豚鼠肝脏微粒体中的药物代谢活性低于苯巴比妥处理的动物。SKF - 525A处理动物药物代谢活性低归因于P450GP - 1与SKF - 525A代谢物之间形成了代谢中间复合物。这些结果使我们得出结论,豚鼠属于CYP2B亚家族的P450在表达上的组织特异性以及对化学物质的诱导性与大鼠CYP2B1相似,尽管豚鼠肝脏P450GP - 1的组成型表达远高于CYP2B1。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验